Atlas FDA

XIENCE V Everolimus Eluting Coronary Stent System; XIENCE nano EECSS

FDA premarket approval P070015/S134 · decided 2017-02-21

Approval details

PMA number
P070015
Supplement
S134
Supplement type
135 Review Track For 30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
XIENCE V Everolimus Eluting Coronary Stent System; XIENCE nano EECSS
Generic name
Coronary drug-eluting stent
Applicant
Abbott Vascular, Inc.
Date received
2016-09-12
Decision date
2017-02-21
Days to decision
162 days
Decision code
APPR
Product code
NIQ
Advisory committee
Cardiovascular
Expedited review
No
Location
Temecula, CA
Statement
Approval for the use of an alternate test method, Fourier Transform Near Infra-Red Spectroscopy (FT-NIR), for the testing of in-process drug coating solution. This method will be used as an alternate to the current High Performance Liquid Chromatography (HPLC) methods.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Hi-Torque JET Guide Wire Family (K142415)Abbott Vascular, Inc.2014-12-19
PROGRESS GUIDE WIRE FAMILY, PILOT GUIDE WIRE FAMILY (K123067)Abbott Vascular, Inc.2013-01-29
HI-TORQUE COMMAND GUIDE WIRE FAMILY (K122573)Abbott Vascular, Inc.2012-11-20
ARMADA 14 PTA CATHETER (K102705)Abbott Vascular, Inc.2010-12-07
HI-TORQUE WINN GUIDE WIRE FAMILY (K101648)Abbott Vascular, Inc.2010-07-08
HI-TORQUE BALANCE MIDDLEWEIGHT UNIVERSAL (K101011)Abbott Vascular, Inc.2010-05-24
HI-TORQUE PROGRESS GUIDE WIRE FAMILY (K091825)Abbott Vascular, Inc.2009-09-25
FOXCROSS PTA CATHETER (K081417)Abbott Vascular, Inc.2008-06-04